Shardul Amarchand Mangaldas & Co. advises Novo Holdings A/S on its investment in MedGenome Inc.
This investment will enable the company in expanding its genomics and integrated diagnostics solutions across India and other emerging markets with a focus on early detection and targeted disease management through affordable genetic and integrated diagnostics tools.